What is it about?
Our experiences tell that some cases with diabetes now receiving intensive insulin therapy could be switched to more reasonable and patient-friendly therapeutic option.
Featured Image
Why is it important?
We hope that a certain part of undiagnosed cases with neonatal diabetes mellitus could be benefitted from the change in glycemic control methods following our experience.
Read the Original
This page is a summary of: A case with relapsed transient neonatal diabetes mellitus treated with sulfonylurea, ending chronic insulin requirement, Endocrinology Diabetes and Metabolism Case Reports, April 2018, Bioscientifica,
DOI: 10.1530/edm-18-0005.
You can read the full text:
Contributors
The following have contributed to this page
